Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells
暂无分享,去创建一个
O. Burrone | J. Rana | M. Bestagno | J. L. Slon Campos | M. Poggianella | M. Mossenta | S. Marchese | J. L. S. Campos | Jyoti Rana
[1] O. Burrone,et al. Role of N-glycosylation on Zika virus E protein secretion, viral assembly and infectivity. , 2017, Biochemical and biophysical research communications.
[2] R. Baric,et al. Neutralization mechanism of a highly potent antibody against Zika virus , 2016, Nature Communications.
[3] J. Low,et al. Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity , 2016, Nature Microbiology.
[4] T. Pierson,et al. Zika Virus Is Not Uniquely Stable at Physiological Temperatures Compared to Other Flaviviruses , 2016, mBio.
[5] M. Beltramello,et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection , 2016, Science.
[6] C. Nelson,et al. Structural Basis of Zika Virus-Specific Antibody Protection , 2016, Cell.
[7] J. Mascola,et al. Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype. , 2016, Cell reports.
[8] Anavaj Sakuntabhai,et al. Structural basis of potent Zika–dengue virus antibody cross-neutralization , 2016, Nature.
[9] R. Baric,et al. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus , 2016, mBio.
[10] J. Wrammert,et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus , 2016, Proceedings of the National Academy of Sciences.
[11] G. Screaton,et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus , 2016, Nature Immunology.
[12] S. Rasmussen,et al. Zika Virus and Birth Defects--Reviewing the Evidence for Causality. , 2016, The New England journal of medicine.
[13] G. Screaton,et al. New insights into the immunopathology and control of dengue virus infection , 2015, Nature Reviews Immunology.
[14] J. Lai,et al. Comprehensive mapping of functional epitopes on dengue virus glycoprotein E DIII for binding to broadly neutralizing antibodies 4E11 and 4E5A by phage display. , 2015, Virology.
[15] O. Burrone,et al. Secretion of dengue virus envelope protein ectodomain from mammalian cells is dependent on domain II serotype and affects the immune response upon DNA vaccination. , 2015, The Journal of general virology.
[16] E. Harris,et al. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers , 2015, Science.
[17] E. Ooi,et al. Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes , 2015, PLoS neglected tropical diseases.
[18] Jacky Flipse,et al. The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response , 2015, PLoS neglected tropical diseases.
[19] V. Kostyuchenko,et al. A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins , 2015, Nature Communications.
[20] Cameron P Simmons,et al. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus , 2014, Nature Immunology.
[21] P. Desprès,et al. Recognition determinants of broadly neutralizing human antibodies against dengue viruses , 2015, Nature.
[22] Bhumi P. Patel,et al. Dengue Viruses Are Enhanced by Distinct Populations of Serotype Cross-Reactive Antibodies in Human Immune Sera , 2014, PLoS pathogens.
[23] Steven F. Baker,et al. Influenza A and B Virus Intertypic Reassortment through Compatible Viral Packaging Signals , 2014, Journal of Virology.
[24] V. Nerurkar,et al. Characterization of the Ectodomain of the Envelope Protein of Dengue Virus Type 4: Expression, Membrane Association, Secretion and Particle Formation in the Absence of Precursor Membrane Protein , 2014, PloS one.
[25] E. Harris,et al. A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface , 2014, EMBO molecular medicine.
[26] Victor A. Kostyuchenko,et al. Immature and Mature Dengue Serotype 1 Virus Structures Provide Insight into the Maturation Process , 2013, Journal of Virology.
[27] Jiaqi Wang,et al. Structural Changes in Dengue Virus When Exposed to a Temperature of 37°C , 2013, Journal of Virology.
[28] Luke N Robinson,et al. Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency , 2013, Proceedings of the National Academy of Sciences.
[29] Richard J Kuhn,et al. Dengue structure differs at the temperatures of its human and mosquito hosts , 2013, Proceedings of the National Academy of Sciences.
[30] John S. Brownstein,et al. The global distribution and burden of dengue , 2013, Nature.
[31] James E. Robinson,et al. Mechanistic Study of Broadly Neutralizing Human Monoclonal Antibodies against Dengue Virus That Target the Fusion Loop , 2012, Journal of Virology.
[32] M. Diamond,et al. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions , 2012, Proceedings of the National Academy of Sciences.
[33] Cameron P. Simmons,et al. Current concepts: Dengue , 2012 .
[34] C. Huang,et al. Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion. , 2011, Virology.
[35] M. Guzmán,et al. The Complexity of Antibody-Dependent Enhancement of Dengue Virus Infection , 2010, Viruses.
[36] M. Kielian,et al. In Vitro and In Vivo Studies Identify Important Features of Dengue Virus pr-E Protein Interactions , 2010, PLoS pathogens.
[37] Prida Malasit,et al. Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans , 2010, Science.
[38] M. Accavitti-Loper,et al. Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. , 2009, Virology.
[39] D. Beckett,et al. A minimal peptide substrate in biotin holoenzyme synthetase‐catalyzed biotinylation , 2008, Protein science : a publication of the Protein Society.
[40] T. Pierson,et al. Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation. , 2008, Virology.
[41] Richard J Kuhn,et al. Structural proteomics of dengue virus. , 2008, Current opinion in microbiology.
[42] A. López-Requena,et al. In vivo site-specific biotinylation of proteins within the secretory pathway using a single vector system , 2008, BMC biotechnology.
[43] Ying Zhang,et al. The Flavivirus Precursor Membrane-Envelope Protein Complex: Structure and Maturation , 2008, Science.
[44] Wei Zhang,et al. Structure of the Immature Dengue Virus at Low pH Primes Proteolytic Maturation , 2008, Science.
[45] Gregory D. Gromowski,et al. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. , 2007, Virology.
[46] R. Doms,et al. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. , 2006, Virology.
[47] R. Doms,et al. N-Linked Glycosylation of West Nile Virus Envelope Proteins Influences Particle Assembly and Infectivity , 2005, Journal of Virology.
[48] Y. Modis,et al. Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein , 2005, Journal of Virology.
[49] W. Weissenhorn,et al. Class I and class II viral fusion protein structures reveal similar principles in membrane fusion (Review) , 2004, Molecular membrane biology.
[50] Timothy S Baker,et al. Conformational changes of the flavivirus E glycoprotein. , 2004, Structure.
[51] K. Stiasny,et al. Structure of a flavivirus envelope glycoprotein in its low‐pH‐induced membrane fusion conformation , 2004, The EMBO journal.
[52] Y. Modis,et al. Structure of the dengue virus envelope protein after membrane fusion , 2004, Nature.
[53] Daniele Sblattero,et al. Binders based on dimerised immunoglobulin VH domains. , 2003, Journal of molecular biology.
[54] Ying Zhang,et al. Structures of immature flavivirus particles , 2003, The EMBO journal.
[55] A. Helenius,et al. Folding and Dimerization of Tick-Borne Encephalitis Virus Envelope Proteins prM and E in the Endoplasmic Reticulum , 2002, Journal of Virology.
[56] Wei Zhang,et al. Structure of Dengue Virus Implications for Flavivirus Organization, Maturation, and Fusion , 2002, Cell.
[57] J. Roehrig,et al. Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells , 2001, Journal of Virology.
[58] C. Mandl,et al. Mutational Evidence for an Internal Fusion Peptide in Flavivirus Envelope Protein E , 2001, Journal of Virology.
[59] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[60] O. Burrone,et al. Mammalian cell expression of dimeric small immune proteins (SIP). , 1997, Protein engineering.
[61] S. Harrison,et al. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution , 1995, Nature.
[62] R. Randall,et al. Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen. , 1992, The Journal of general virology.
[63] M. K. Gentry,et al. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. , 1982, The American journal of tropical medicine and hygiene.
[64] L. R. Petersen,et al. Zika Virus. , 2016, The New England journal of medicine.
[65] J.,et al. The New England Journal of Medicine , 2012 .
[66] M. Rossmann,et al. A structural perspective of the flavivirus life cycle , 2005, Nature Reviews Microbiology.